Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Seneca Biopharm Inc (SNCA)

Seneca Biopharm Inc (SNCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,711
  • Shares Outstanding, K 17,296
  • Annual Sales, $ 10 K
  • Annual Income, $ -16,270 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.88
  • Price/Sales 2,075.52
  • Price/Cash Flow N/A
  • Price/Book 2.94
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.52
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 05/21/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3400 +23.88%
on 04/16/21
1.8900 -12.17%
on 04/06/21
+0.1100 (+7.10%)
since 03/26/21
3-Month
1.0301 +61.15%
on 03/04/21
2.6700 -37.83%
on 03/22/21
+0.3100 (+22.96%)
since 01/27/21
52-Week
0.5001 +231.93%
on 09/24/20
2.6700 -37.83%
on 03/22/21
+0.8868 (+114.69%)
since 04/27/20

Most Recent Stories

More News
Leading BioSciences Announces Early Efficacy Signal in Reducing Post-Surgical Adhesions in Open Label Study

CARLSBAD, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Leading BioSciences, Inc. (“LBS” or "the Company"), a privately held company that recently entered into a definitive agreement for a reverse merger...

SNCA : 9.9600 (-1.19%)
Leading BioSciences Provides Update to Seneca Biopharma, Inc. Stockholders on Merger Closing Process Following Virtual Special Meeting on April 23, 2021 and Upcoming Milestones Following Planned Close of Merger

Video message details merger closing process following completion of the April 23 virtual Special Meeting as well as next planned milestones for the merged company to be renamed Palisade Bio

SNCA : 9.9600 (-1.19%)
Leading BioSciences Releases Video Message Encouraging Seneca Biopharma, Inc. Stockholders to Vote at the Virtual Special Meeting on April 23, 2021

Video messages urges Seneca stockholders to vote in support of Proposal #1, the reverse stock split, in order to approve the proposed transaction.

SNCA : 9.9600 (-1.19%)
Leading BioSciences Releases Video Message Highlighting Compelling Investment Thesis of Proposed Merger with Seneca Biopharma, Inc.

Video message explains the multiple benefits of the proposed merger and provides an overview of the substantial market opportunity for the combined company to be named Palisade Bio

SNCA : 9.9600 (-1.19%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates CUB, SYNC, PTVCA, SNCA; Shareholders Are Encouraged to Contact the Firm

NEW YORK, March 08, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

CUB : 10.07 (-0.30%)
SYNC : 2.19 (-0.45%)
PTVCA : 23.27 (+0.04%)
SNCA : 9.9600 (-1.19%)
Leading BioSciences to Present at the H.C. Wainwright Global Life Sciences Conference

CARLSBAD, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Leading BioSciences, Inc. (“LBS”), a privately held company that recently entered into a definitive agreement for a reverse merger with Seneca...

SNCA : 9.9600 (-1.19%)
PALI : 2.3600 (+68.57%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates GWPH, COHR, FLIR, SNCA; Shareholders Are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / February 9, 2021 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: GW Pharmaceuticals plc (NASDAQ:GWPH) concerning potential...

GWPH : 218.96 (-0.15%)
COHR : 104.08 (+0.23%)
FLIR : 57.34 (-0.31%)
SNCA : 9.9600 (-1.19%)
ALERT: Halper Sadeh LLP Investigates TCP, SMTX, SNCA, MTSC; Shareholders Are Encouraged to Contact the Firm

NEW YORK, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

TCP : 30.21 (+1.65%)
SMTX : 6.04 (+0.50%)
SNCA : 9.9600 (-1.19%)
MTSC : 58.49 (-0.02%)
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates RP, CHNG, TCP, SNCA; Shareholders Are Encouraged to Contact the Firm

NEW YORK, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies:

RP : 88.72 (+0.08%)
CHNG : 27.49 (+0.26%)
TCP : 30.21 (+1.65%)
SNCA : 9.9600 (-1.19%)
SENECA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Seneca Biopharma, Inc. - SNCA

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Seneca Biopharma, Inc. (NasdaqGS: SNCA) with...

SNCA : 9.9600 (-1.19%)

Business Summary

Seneca Biopharma Inc. is a clinical-stage biopharmaceutical company. It focuses on developing novel treatments for diseases of unmet medical need. Seneca Biopharma Inc., formerly known as Neuralstem Inc, is based in GERMANTOWN, Md.

See More

Key Turning Points

3rd Resistance Point 1.7322
2nd Resistance Point 1.7017
1st Resistance Point 1.6809
Last Price 9.9600
1st Support Level 1.6296
2nd Support Level 1.5991
3rd Support Level 1.5783

See More

Last Price 9.9600
52-Week High 2.6700
Fibonacci 61.8% 1.8411
Fibonacci 50% 1.5851
Fibonacci 38.2% 1.3290
52-Week Low 0.5001

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar